SCHEMBL25018087

SCHEMBL25018087

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4sc5c(-c6nc(-c7cccc8c7sc7ccccc78)nc7c6sc6ccccc67)cccc5c34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.38
▸ LIMK1 P53667 3/20 0.36
▸ PARP14 Q460N5 1/20 0.34
▸ ATM Q13315 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TNKS O95271 3/20 0.32
▸ TNKS2 Q9H2K2 3/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ TSHR P16473 2/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016728 1.00 ALOX5 (0.38) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL25016302 1.00 ALOX5 (0.38) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL22329602 0.96 LIMK1 (0.38) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL25017451 0.95 ALOX5 (0.41) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL22195675 0.95 ALOX5 (0.38) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL25017055 0.95 ALOX5 (0.38) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL22329296 0.94 LIMK1 (0.37) ALOX5LIMK1ATMMEN1KMT2A
SCHEMBL22330131 0.94 LIMK1 (0.37) ALOX5LIMK1ATMMEN1KMT2A
SCHEMBL25017483 0.94 LIMK1 (0.37) ALOX5LIMK1PARP14ATMMEN1
SCHEMBL23686336 0.94 LIMK1 (0.38) ALOX5LIMK1PARP14ATMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 ALOX5 366/4885LIMK1 389/4885PARP14 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback